Article Versions Notes

Suliman RS, Alghamdi SS, Ali R, Aljatli D, Aljammaz NA, Huwaizi S, Suliman R, Kahtani KM, Albadrani GM, Barhoumi T, et al. The Role of Myrrh Metabolites in Cancer, Inflammation, and Wound Healing: Prospects for a Multi-Targeted Drug Therapy. Pharmaceuticals. 2022; 15(8):944. https://doi.org/10.3390/ph15080944

Suliman, Rasha Saad, Sahar Saleh Alghamdi, Rizwan Ali, Dimah Aljatli, Norah Abdulaziz Aljammaz, Sarah Huwaizi, Rania Suliman, Khawla Mohammed Kahtani, Ghadeer M. Albadrani, Tlili Barhoumi, and et al. 2022. "The Role of Myrrh Metabolites in Cancer, Inflammation, and Wound Healing: Prospects for a Multi-Targeted Drug Therapy" Pharmaceuticals 15, no. 8: 944. https://doi.org/10.3390/ph15080944

Suliman, R. S., Alghamdi, S. S., Ali, R., Aljatli, D., Aljammaz, N. A., Huwaizi, S., Suliman, R., Kahtani, K. M., Albadrani, G. M., Barhoumi, T., Altolayyan, A., & Rahman, I. (2022). The Role of Myrrh Metabolites in Cancer, Inflammation, and Wound Healing: Prospects for a Multi-Targeted Drug Therapy. Pharmaceuticals, 15(8), 944. https://doi.org/10.3390/ph15080944